APP and cancer: Because in vitro studies showed induction of apoptosis via DNA damage in both cancer and normal cells in a dose-dependent manner after APP treatments, follow-up ex vivo [15] and in vivo [9] studies were conducted to investigate those processes under more realistic conditions.